Literature DB >> 18778568

Parathyroid hormone and the cardiovascular system.

Lorraine A Fitzpatrick1, John P Bilezikian, Shonni J Silverberg.   

Abstract

The classical actions of parathyroid hormone (PTH) are well recognized, but its effects on other target tissues, such as the cardiovascular system, are less appreciated. Several studies have evaluated the effects of PTH in patients with primary hyperparathyroidism in order to understand potential cardiovascular effects in terms of hypertension, cardiovascular mortality, left ventricular function, and endothelial function. We review these studies and evaluate the cellular mechanisms that may affect these outcomes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18778568     DOI: 10.1007/s11914-008-0014-8

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN: 1544-1873            Impact factor:   5.096


  53 in total

1.  Arterial stiffness in mild primary hyperparathyroidism.

Authors:  Mishaela R Rubin; Mathew S Maurer; Donald J McMahon; John P Bilezikian; Shonni J Silverberg
Journal:  J Clin Endocrinol Metab       Date:  2005-03-15       Impact factor: 5.958

2.  Endothelin concentrations are elevated in plasma of patients with primary and secondary hyperparathyroidism.

Authors:  P Lakatos; A Tátrai; J Földes; C Horváth; J Makó; P H Stern
Journal:  Calcif Tissue Int       Date:  1996-01       Impact factor: 4.333

3.  Serum calcium and survival in a large health screening program.

Authors:  B G Leifsson; B Ahrén
Journal:  J Clin Endocrinol Metab       Date:  1996-06       Impact factor: 5.958

4.  Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy.

Authors:  A Piovesan; N Molineri; F Casasso; I Emmolo; G Ugliengo; F Cesario; G Borretta
Journal:  Clin Endocrinol (Oxf)       Date:  1999-03       Impact factor: 3.478

5.  Maintained normalization of cardiovascular dysfunction 5 years after parathyroidectomy in primary hyperparathyroidism.

Authors:  Inga-Lena Nilsson; Jan Aberg; Jonas Rastad; Lars Lind
Journal:  Surgery       Date:  2005-06       Impact factor: 3.982

6.  Increased plasma N-terminal pro-B-type natriuretic peptide and markers of inflammation related to atherosclerosis in patients with primary hyperparathyroidism.

Authors:  Christina Gerlach Ogard; Mads D Engelmann; Caroline Kistorp; Steen Levin Nielsen; Henrik Vestergaard
Journal:  Clin Endocrinol (Oxf)       Date:  2005-11       Impact factor: 3.478

7.  Positive chronotropic actions of parathyroid hormone and parathyroid hormone-related peptide are associated with increases in the current, I(f), and the slope of the pacemaker potential.

Authors:  M Hara; Y M Liu; L Zhen; I S Cohen; H Yu; P Danilo; K Ogino; J P Bilezikian; M R Rosen
Journal:  Circulation       Date:  1997-11-18       Impact factor: 29.690

Review 8.  Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide.

Authors:  K D Schlüter; H M Piper
Journal:  Cardiovasc Res       Date:  1998-01       Impact factor: 10.787

9.  Cardiac dysfunction in mild primary hyperparathyroidism assessed by radionuclide angiography and echocardiography before and after parathyroidectomy.

Authors:  Erik G Almqvist; Anne-Greth Bondeson; Lennart Bondeson; Anders Nissborg; Peter Smedgård; Sven-Eric Svensson
Journal:  Surgery       Date:  2002-12       Impact factor: 3.982

10.  Serum parathyroid hormone levels predict coronary heart disease: the Tromsø Study.

Authors:  Elena Kamycheva; Johan Sundsfjord; Rolf Jorde
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2004-02
View more
  28 in total

1.  Secondary hyperparathyroidism prevalence and prognostic role in elderly males with heart failure.

Authors:  G Loncar; B Bozic; N Cvetinovic; H-D Dungen; M Lainscak; S von Haehling; W Doehner; Z Radojicic; B Putnikovic; T Trippel; V Popovic
Journal:  J Endocrinol Invest       Date:  2016-10-13       Impact factor: 4.256

2.  Low vitamin D status associated with dilated cardiomyopathy.

Authors:  Veli Polat; Evin Bozcali; Turgut Uygun; Selçuk Opan; Osman Karakaya
Journal:  Int J Clin Exp Med       Date:  2015-01-15

3.  Parathyroid hormone is related to QT interval independent of serum calcium in patients with coronary artery disease.

Authors:  Nicholas O Palmeri; Karina W Davidson; William Whang; Ian M Kronish; Donald Edmondson; Marcella D Walker
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-09-26       Impact factor: 1.468

Review 4.  Vitamin D and cardiovascular disease prevention.

Authors:  Stefan Pilz; Nicolas Verheyen; Martin R Grübler; Andreas Tomaschitz; Winfried März
Journal:  Nat Rev Cardiol       Date:  2016-05-06       Impact factor: 32.419

5.  Parathyroid hormone and the risk of incident hypertension: the Atherosclerosis Risk in Communities study.

Authors:  Lu Yao; Aaron R Folsom; James S Pankow; Elizabeth Selvin; Erin D Michos; Alvaro Alonso; Weihong Tang; Pamela L Lutsey
Journal:  J Hypertens       Date:  2016-02       Impact factor: 4.844

6.  Role of Vitamin D in the Outcome of Ischemic Stroke- A Randomized Controlled Trial.

Authors:  Shuba Narasimhan; Prakash Balasubramanian
Journal:  J Clin Diagn Res       Date:  2017-02-01

Review 7.  Vitamin D deficiency and essential hypertension.

Authors:  Songcang Chen; Yingxian Sun; Devendra K Agrawal
Journal:  J Am Soc Hypertens       Date:  2015-08-21

Review 8.  Vitamin D status and arterial hypertension: a systematic review.

Authors:  Stefan Pilz; Andreas Tomaschitz; Eberhard Ritz; Thomas R Pieber
Journal:  Nat Rev Cardiol       Date:  2009-08-18       Impact factor: 32.419

Review 9.  Primary hyperparathyroidism and hypertension.

Authors:  Sarah B Fisher; Nancy D Perrier
Journal:  Gland Surg       Date:  2020-02

10.  Low levels of 25-hydroxyvitamin D in the pediatric populations: prevalence and clinical outcomes.

Authors:  Michal L Melamed; Juhi Kumar
Journal:  Ped Health       Date:  2010-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.